Who
Alison Bauerlein
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Sight Sciences; Director, Pear Therapeutics; Director, Gelesis Holdings; EVP, Finance, & CFO, Inogen.
In numbers
- Trades disclosed
- 251
- Buys
- 0
- Sells
- 52
- Bought
- $0
- Sold
- $25.5M
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 1 Apr 2014
- Last trade
- 2 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 5 Oct 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $224K25,260 at $8.85 | filing |
| 2 Jul 2026filed 6 Jul 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $130K24,184 at $5.36 | filing |
| 2 Jul 2026filed 6 Jul 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $130K24,184 at $5.36 | filing |
| 18 May 2026filed 19 May 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $65K12,728 at $5.12 | filing |
| 18 May 2026filed 19 May 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $65K12,728 at $5.12 | filing |
| 2 Apr 2026filed 3 Apr 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $90K25,874 at $3.48 | filing |
| 2 Apr 2026filed 3 Apr 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $90K25,874 at $3.48 | filing |
| 3 Feb 2026filed 5 Feb 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —127,512 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —127,512 at $0.00 | filing |
| 6 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $72K9,647 at $7.48 | filing |
| 6 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $72K9,647 at $7.48 | filing |
| 5 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $85K10,896 at $7.82 | filing |
| 5 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $85K10,896 at $7.82 | filing |
| 11 Nov 2025filed 13 Nov 2025 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —23,006 at $0.00 | filing |
| 2 Oct 2025filed 3 Oct 2025 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $66K19,948 at $3.30 | filing |
| 2 Jul 2025filed 7 Jul 2025 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $79K19,260 at $4.10 | filing |
| 19 May 2025filed 21 May 2025 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $45K13,066 at $3.48 | filing |
| 2 Apr 2025filed 3 Apr 2025 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $45K19,397 at $2.31 | filing |
| 11 Mar 2025filed 13 Mar 2025 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —286,738 at $0.00 | filing |
| 3 Jan 2025filed 6 Jan 2025 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $36K10,102 at $3.52 | filing |
News
Insider Selling: Sight Sciences (NASDAQ:SGHT) CTO Sells $70,562.85 in StockSGHT · themarketsdaily.com · 8 Oct 2026Financial Contrast: Nano-X Imaging (NASDAQ:NNOX) & Sight Sciences (NASDAQ:SGHT)SGHT · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name Alison Bauerlein; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.